We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.75 | 10.50 | 11.00 | 10.75 | 10.50 | 10.75 | 211,065 | 10:07:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.79 | 13.08M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/8/2021 18:56 | Not convinced Myles knows anything more than anyone else about manufacturing volumes or timeframes. If AVCT have such confidence that everything that they make will sell - why don't they fund ABDX to make them quicker?? what has taken so long for tech transfer?? | mikro1 | |
18/8/2021 17:13 | Myles better than thing I've read recently.hTTps://aim | grosstonnage | |
12/8/2021 13:27 | cumnor Don't blame everything on the Tories. The decision to withhold payment must be down to a senior civil servant and will have to be justified in due course. If the Secretary of State were to insist on payment being made before the outcome of the Judicial Review, he would expose himself to serious embarrassment in the unlikely event of ABDX being found to have behaved improperly. It is certainly true that some leading Tories are perceived as corruptible. I do not seek to defend them but I cannot see this surprising behaviour by the Department of Health as an instance of Tory corruption or betrayal of Northerners. It is indeed very hard on ABDX, its workforce and us shareholders that we should have to wait until December for the Review. Having lost 70% of my money here I feel as sore as you do ! | varies | |
12/8/2021 09:23 | Just bought some of these, not least because the CEO is prepared to take on the Tories and highlight the betrayal of the so called Northern Powerhouse by Boris Johnson. | cumnor | |
12/8/2021 09:09 | RNS 12/08/2021 - "The Company has not seen significant commercial traction with the AbC-19(TM) product to date". That's all you need to know. | pwhite73 | |
12/8/2021 08:15 | She constantly fails... cannot fathom how she’s constantly given high ranking roles!!! Must be giving awesome head D | dennisbergkamp | |
09/8/2021 17:46 | The position stated by ABDX clarifies most, if not all of the serious accusations posed by the GLP. GLP are going to have to work hard to restate their position against the evidence offered in the letter from Abingdon Health. Given the support from Abingdon CEO Chris Yeates, Govt could now do the decent thing and pay the outstanding balance, which would clear up another grey area. | bamboo2 | |
04/8/2021 08:04 | Avacta RNS could be significant. | grosstonnage | |
04/8/2021 07:44 | AVCT RNS may have read across here today and into the future regarding manufacture of Avacta,s LFT. | grosstonnage | |
31/7/2021 16:06 | Once you look at the range that Biosure have lined up, the manufacturing deal looks good... Brigette Bard, CEO of BioSURE, added: “We are thrilled to be continuing to build our portfolio of products with Abingdon. BioSure is committed to delivering British developed tests to the global market and Abingdon are our ideal partner..." Vatic looks interesting, and if it becomes as popular as it might do it would be good if ABDX are involved in manufacture. ==================== The tests supplied to MHRA in January 2021 have stated to be used in a phase two trial by the UK Biobank See Frequently asked questions section here, "Who bought the antibody test kits? The kits were donated to UK Biobank by the Department of Health and Social Care." Now they have been put to use, I would think that payment should be imminent. I have emailed the company for their viewpoint. | bamboo2 | |
23/7/2021 13:26 | market sentiment is not interested right now. Wait until autumn. unless there is an interesting RNS | cottlet | |
22/7/2021 15:19 | Why is the management so quiet? What is going on to create value? This is off almost £1 from post float high. | cdd24 | |
15/7/2021 16:51 | Watch the recent Public Accounts committee, ignore Dido Harding as she squirms uncomfortably on her seat, and focus on the outlook given by Dr Jenny Harries. It's a fascinating insight. ...Dr Jenny Harries, Chief Executive of UK Health Security Agency, gave feedback during the UK Government’s Public Accounts Committee discussing the importance of antibody testing in the near future. Saying, “antibody testing is likely to come back” because “it’s important that we understand who has had a good response”. Dr Harries’ comments shed light on the importance of antibody-presence in determining a successful immune response post-vaccination, or indeed infection, or both... | bamboo2 | |
15/7/2021 16:27 | What's behind the recovery in the sp? The realisation that jabs and test passports alone will not be enough to fully open up. For the sake of a few more pounds, Antibody testing is also likely to become a requirement. [It means your jab is working, you are unlikely to be a symptomless carrier, AND you are unlikely to become unwell.] | bamboo2 | |
15/7/2021 15:16 | "Does anyone know why the share price shot up ?" Were you waving it ? :) its up a couple of p, who knows ? | twatcher |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions